Location History:
- Tokyo, JP (1991)
- Shizuoka, JP (2011)
Company Filing History:
2 out of 950 
1 out of 2 Years Active: 1991-2011
Title: The Innovations of Makoto Sugawa
Introduction
Makoto Sugawa is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of demyelinating diseases and peripheral circulatory disorders. With a total of 2 patents, Sugawa's work has the potential to impact many lives.
Latest Patents
One of Sugawa's latest patents is a pharmaceutical for the prevention and treatment of demyelinating diseases. This innovative pharmaceutical contains erythropoietin as an active ingredient, which acts protectively on the survival of oligodendrocytes. These cells are crucial for forming the myelin sheath in conditions such as cerebrovascular dementia, multiple sclerosis, and Binswanger disease. The pharmaceutical not only protects oligodendrocytes but also promotes the maturation of undifferentiated oligodendrocytes in the brain, thereby activating remyelination. This dual action can help prevent and treat neural function impairing diseases associated with demyelination.
Another significant patent involves dibenzoxazepine compounds useful in treating cerebral vasospasm. This therapeutic agent is designed for the treatment of peripheral circulatory disorders and contains a dibenzoxazepin derivative as its effective ingredient. The method for treatment involves administering this compound to patients suffering from such disorders, showcasing Sugawa's commitment to addressing critical health issues.
Career Highlights
Throughout his career, Makoto Sugawa has worked with notable organizations, including Chugai Pharmaceutical Co., Ltd. and the Tokyo Metropolitan Institute of Gerontology. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Sugawa has collaborated with esteemed colleagues such as Hiroaki Asou and Yukijumi Noda. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Makoto Sugawa's contributions to the field of pharmaceuticals demonstrate his dedication to improving health outcomes through innovation. His patents reflect a deep understanding of complex medical conditions and a commitment to finding effective treatments.